NCT05314088Completed
Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
Source: ClinicalTrials.gov · Last updated 4 Sept 2026
Brief summary (registry, in English)
This study will examine the mechanisms and efficacy of a resilience building intervention in older people living with HIV.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 82 (actual)
- First submitted
- 21 Mar 2022
- Start date
- 3 Feb 2023
- Primary completion date
- 31 May 2025
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- HIV
- NCT number
- NCT05314088
What you commit to
- Study type: Interventional
- Participants enrolled: 82
- From 3 Feb 2023 to the primary completion date, 31 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- neurological or severe psychiatric (e.g., schizophrenia, bipolar disorder, major depression) disorders
Who the study is looking for
- current UAB HIV Clinic patient
- age 50+
- have a recent history (within the past 12 months) of suboptimal HIV management, defined as having either ≥one record of detectable viral load or ≥one missed clinic visit without prior cancellation/reschedule
Age in the registry: 50 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Holley Mears Building Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.